Chemotherapy sensitivity and resistance assays

BlueCross BlueShield Association
Record ID 32003000753
Authors' objectives:

This Assessment will review the available evidence to compare the effectiveness of assay-guided chemotherapy with that of empiric chemotherapy. The objective is to determine whether the use of assay-guided chemotherapy improves outcomes such as overall survival or disease-free survival.

Authors' methods: Systematic review
Project Status: Completed
Year Published: 2002
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: United States
MeSH Terms
  • Biological Assay
  • Chemotherapy, Adjuvant
  • Drug Resistance
  • Drug Therapy
  • Neoplasms
Organisation Name: BlueCross BlueShield Association
Contact Address: BlueCross BlueShield Association, Technology Evaluation Center, 225 North Michigan Ave, Chicago, Illinois, USA. Tel: 888 832 4321
Contact Name:
Contact Email:
Copyright: BlueCross BlueShield Association (BCBS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.